Jade Biosciences, Inc.
USD19.67
-1.19 (-5.70%)
CEO
Tom Frohlich
IPO Date
2021-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.82
Prev. Close
$20.86
Day Low
$19.47
Day High
$21.50
52W Low
$6.67
52W High
$28.00
Market Cap
$0.64B
Volume
0.63M
| $0.00 |
| 11 Jun 2026 | CAIN CHRISTOPHER W. | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | DOBMEIER ERIC | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | Klein Lawrence Otto | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | Lavelle Erin | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 34,843 | $15.22 |
| 13 Feb 2026 | Dahms Bradford D. | Chief Financial Officer | A-Award | Acquired | 37,813 | $0.00 |
| 13 Feb 2026 | Dahms Bradford D. | Chief Financial Officer | A-Award | Acquired | 226,875 | $14.81 |
| 13 Feb 2026 | Balta Elizabeth | See Remarks | A-Award | Acquired | 168,750 | $14.81 |